Carmelo Laudanna

28PUBLICATIONS
209CO-AUTHORS
ChemotherapyMolecular targetsTumour immunologyGenome structure and regulationMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

|May 27, 2026
Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.

|Nov 07, 2025
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages.

Ana Henriques, Maria Salvany-Celades, Paula Nieto

|Oct 23, 2025
A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.

Alessia Centonze, Adrià-Jaume Roura, Meritxell Novillo-Font

|Mar 19, 2025
A single-cell resolved genotype-phenotype map using genome-wide genetic and environmental perturbations.

Mariona Nadal-Ribelles, Carme Solé, Anna Díez-Villanueva

|Oct 30, 2024
H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells.

Valentina Ramponi, Laia Richart, Marta Kovatcheva

Pageof 5

Frequent Collaborators

10 joint publications

Manuel Serrano

6 joint publications

Lidia Mateo

6 joint publications

Eduard Batlle

5 joint publications

Holger Heyn